Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-001 for third-line or later advanced pancreatic cancer
ChiCTR-IIR-17013424Phase 2Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Sep 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of K-001 in pancreatic adenocarcinoma (PDAC) (2 arms), sponsored by Renji Hospital. Primary endpoint: overall survival. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
K-001
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on ChiCTR-IIR-17013424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17013424.